Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)

Details for Australian Patent Application No. 2004290624 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Fletcher, Stephen Robert; Burkamp, Frank

Agent Spruson & Ferguson

Pub. Number AU-A-2004290624

PCT Pub. Number WO2005/049601

Priority 0326633.5 14.11.03 GB

Filing date 12 November 2004

Wipo publication date 2 June 2005

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4439 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/049601 Priority application(s): WO2005/049601

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290626-Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)

2004290622-Carton and carton blank